
|Articles|April 28, 2023
Bas Trietsch Discusses Successes so Far Using Organ on a Chip Technology for Bio/Pharmaceuticals (INTERPHEX 2023)
Bas Trietsch, chief technology officer, MIMETAS, discusses the successes he's encountered so far using organ on a chip technology in bio/pharmaceutical research.
Advertisement
Bas Trietsch, chief technology officer, MIMETAS, and one of the INTERPHEX Keynote speakers in the
For more INTERPHEX 2023 video content, check
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Mature Medicines Divestment Signals Shift in Manufacturing Strategy
2
CPHI Milan 2026: AI and Bioavailability, Part 1
3
Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response
4
The Risk File Was Never Meant to Be a Once-a-Year Exercise
5




